New Investigational Medication for patients with Chronic Obstructive Pulmonary Disease with a history of cardiac issues.

This is a clinical trial of about 36  months to evaluate the long term effectiveness and cardiac safety of patients with moderate to very severe COPD and a history of heart disease.

  • Ages greater than or equal to 40
  • Must have a diagnosis of COPD and a history of cardiovascular or cerebrovascular problems or have signs of cardiovascular risk
  • Must have 1 documented COPD exacerbation within 1 year prior to the first study visit.